# Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.

> **NCT03526822** · NA · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 100 (estimated)

## Conditions studied

- Brain Tumor

## Interventions

- **BIOLOGICAL:** Blood sample
- **BIOLOGICAL:** Tumor sample

## Key facts

- **NCT ID:** NCT03526822
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-02
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526822, "Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03526822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*